Health Canada has widened its recall of cannabis oils and softgels, now affecting 14 lots of products from multiple brands. The recall, which began in June, has expanded to include over 17,000 units sold across six provinces and territories between December 2022 and July 2024.

The agency’s inspection revealed significant quantities of intoxicating cannabinoids HHC and THC in products labeled as containing minimal amounts. This mislabeling poses risks to consumers who may unknowingly ingest intoxicating substances.

Several adverse reactions have been reported, prompting Health Canada to warn of potential cannabis poisoning symptoms, including chest pain, rapid heartbeat, and severe anxiety. Consumers are urged to immediately cease using the affected products and return or dispose of them safely.

This recall underscores the importance of accurate labeling in the cannabis industry to ensure consumer safety and informed decision-making.